Table of Contents Table of Contents 2 Introduction 7 Cervical Cancer - Overview 8 Cervical Cancer - Therapeutics Development 9 Cervical Cancer - Therapeutics Assessment 35 Cervical Cancer - Companies Involved in Therapeutics Development 51 Cervical Cancer - Drug Profiles 102 Cervical Cancer - Dormant Projects 986 Cervical Cancer - Discontinued Products 993 Cervical Cancer - Product Development Milestones 994 Appendix 1005

List of Tables Number of Products under Development for Cervical Cancer, H2 2018 29 Number of Products under Development by Companies, H2 2018 31 Number of Products under Development by Universities/Institutes, H2 2018 39 Products under Development by Companies, H2 2018 42 Products under Development by Universities/Institutes, H2 2018 53 Number of Products by Stage and Target, H2 2018 56 Number of Products by Stage and Mechanism of Action, H2 2018 62 Number of Products by Stage and Route of Administration, H2 2018 68 Number of Products by Stage and Molecule Type, H2 2018 70 Cervical Cancer - Pipeline by 3SBio Inc, H2 2018 71 Cervical Cancer - Pipeline by Aadi Bioscience Inc, H2 2018 71 Cervical Cancer - Pipeline by AbbVie Inc, H2 2018 72 Cervical Cancer - Pipeline by Abion Inc, H2 2018 72 Cervical Cancer - Pipeline by Abivax SA, H2 2018 73 Cervical Cancer - Pipeline by Admedus Ltd, H2 2018 73 Cervical Cancer - Pipeline by Advaxis Inc, H2 2018 74 Cervical Cancer - Pipeline by Advenchen Laboratories LLC, H2 2018 74 Cervical Cancer - Pipeline by Agenus Inc, H2 2018 75 Cervical Cancer - Pipeline by Almac Discovery Ltd, H2 2018 75 Cervical Cancer - Pipeline by amcure GmbH, H2 2018 75 Cervical Cancer - Pipeline by Amgen Inc, H2 2018 76 Cervical Cancer - Pipeline by AntiCancer Inc, H2 2018 76 Cervical Cancer - Pipeline by Asana BioSciences LLC, H2 2018 77 Cervical Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2018 77 Cervical Cancer - Pipeline by AstraZeneca Plc, H2 2018 78 Cervical Cancer - Pipeline by Bayer AG, H2 2018 78 Cervical Cancer - Pipeline by BeiGene Ltd, H2 2018 79 Cervical Cancer - Pipeline by Biocon Ltd, H2 2018 79 Cervical Cancer - Pipeline by Bioleaders Corp, H2 2018 80 Cervical Cancer - Pipeline by Biomics Biotechnologies Co Ltd, H2 2018 80 Cervical Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2018 80 Cervical Cancer - Pipeline by Bristol-Myers Squibb Co, H2 2018 81 Cervical Cancer - Pipeline by Cancer Research Technology Ltd, H2 2018 82 Cervical Cancer - Pipeline by Celgene Corp, H2 2018 82 Cervical Cancer - Pipeline by Celleron Therapeutics Ltd, H2 2018 83 Cervical Cancer - Pipeline by Cellestia Biotech AG, H2 2018 83 Cervical Cancer - Pipeline by Clovis Oncology Inc, H2 2018 83 Cervical Cancer - Pipeline by Corvus Pharmaceuticals Inc, H2 2018 84 Cervical Cancer - Pipeline by Cotinga Pharmaceuticals Inc, H2 2018 84 Cervical Cancer - Pipeline by Cue Biopharma Inc, H2 2018 85 Cervical Cancer - Pipeline by CytomX Therapeutics Inc, H2 2018 85 Cervical Cancer - Pipeline by Cytori Therapeutics Inc, H2 2018 86 Cervical Cancer - Pipeline by CZ BioMed Corp, H2 2018 86 Cervical Cancer - Pipeline by Daewon Pharm Co Ltd, H2 2018 87 Cervical Cancer - Pipeline by Daiichi Sankyo Co Ltd, H2 2018 87 Cervical Cancer - Pipeline by DelMar Pharmaceuticals Inc, H2 2018 88 Cervical Cancer - Pipeline by Etubics Corp, H2 2018 88 Cervical Cancer - Pipeline by Eureka Therapeutics Inc, H2 2018 89 Cervical Cancer - Pipeline by EyeGene Inc, H2 2018 89 Cervical Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018 90 Cervical Cancer - Pipeline by FLX Bio Inc, H2 2018 90 Cervical Cancer - Pipeline by Forbius, H2 2018 90 Cervical Cancer - Pipeline by GamaMabs Pharma SA, H2 2018 91 Cervical Cancer - Pipeline by Gene Techno Science Co Ltd, H2 2018 91 Cervical Cancer - Pipeline by Genentech Inc, H2 2018 92 Cervical Cancer - Pipeline by Genetic Immunity Inc, H2 2018 92 Cervical Cancer - Pipeline by Genexine Inc, H2 2018 93 Cervical Cancer - Pipeline by Genmab A/S, H2 2018 93 Cervical Cancer - Pipeline by GlaxoSmithKline Plc, H2 2018 94 Cervical Cancer - Pipeline by Glycostem Therapeutics BV, H2 2018 94 Cervical Cancer - Pipeline by Gradalis Inc, H2 2018 94 Cervical Cancer - Pipeline by Immunitor Inc, H2 2018 95 Cervical Cancer - Pipeline by Immunomedics Inc, H2 2018 95 Cervical Cancer - Pipeline by IMV Inc, H2 2018 96 Cervical Cancer - Pipeline by Incyte Corp, H2 2018 96 Cervical Cancer - Pipeline by Innate Pharma SA, H2 2018 97 Cervical Cancer - Pipeline by InSight Biopharmaceuticals Ltd, H2 2018 97 Cervical Cancer - Pipeline by Iovance Biotherapeutics Inc, H2 2018 98 Cervical Cancer - Pipeline by ISA Pharmaceuticals BV, H2 2018 98 Cervical Cancer - Pipeline by JHL Biotech Inc, H2 2018 98 Cervical Cancer - Pipeline by Johnson & Johnson, H2 2018 99 Cervical Cancer - Pipeline by Juno Therapeutics Inc, H2 2018 99 Cervical Cancer - Pipeline by Karyopharm Therapeutics Inc, H2 2018 100 Cervical Cancer - Pipeline by Kite Pharma Inc, H2 2018 101List of Figures Number of Products under Development for Cervical Cancer, H2 2018 29 Number of Products under Development by Companies, H2 2018 30 Number of Products under Development by Universities/Institutes, H2 2018 39 Number of Products by Top 10 Targets, H2 2018 55 Number of Products by Stage and Top 10 Targets, H2 2018 55 Number of Products by Top 10 Mechanism of Actions, H2 2018 61 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018 61 Number of Products by Top 10 Routes of Administration, H2 2018 67 Number of Products by Stage and Top 10 Routes of Administration, H2 2018 67 Number of Products by Top 10 Molecule Types, H2 2018 69 Number of Products by Stage and Top 10 Molecule Types, H2 2018 69

3SBio Inc Aadi Bioscience Inc AbbVie Inc Abion Inc Abivax SA Admedus Ltd Advaxis Inc Advenchen Laboratories LLC Agenus Inc Almac Discovery Ltd amcure GmbH Amgen Inc AntiCancer Inc Asana BioSciences LLC Astex Pharmaceuticals Inc AstraZeneca Plc Bayer AG BeiGene Ltd Biocon Ltd Bioleaders Corp Biomics Biotechnologies Co Ltd Boehringer Ingelheim GmbH Bristol-Myers Squibb Co Cancer Research Technology Ltd Celgene Corp Celleron Therapeutics Ltd Cellestia Biotech AG Clovis Oncology Inc Corvus Pharmaceuticals Inc Cotinga Pharmaceuticals Inc Cue Biopharma Inc CytomX Therapeutics Inc Cytori Therapeutics Inc CZ BioMed Corp Daewon Pharm Co Ltd Daiichi Sankyo Co Ltd DelMar Pharmaceuticals Inc Etubics Corp Eureka Therapeutics Inc EyeGene Inc F. Hoffmann-La Roche Ltd FLX Bio Inc Forbius GamaMabs Pharma SA Gene Techno Science Co Ltd Genentech Inc Genetic Immunity Inc Genexine Inc Genmab A/S GlaxoSmithKline Plc Glycostem Therapeutics BV Gradalis Inc Immunitor Inc Immunomedics Inc IMV Inc Incyte Corp Innate Pharma SA InSight Biopharmaceuticals Ltd Iovance Biotherapeutics Inc ISA Pharmaceuticals BV JHL Biotech Inc Johnson & Johnson Juno Therapeutics Inc Karyopharm Therapeutics Inc Kite Pharma Inc Loxo Oncology Inc MedImmune LLC Merck & Co Inc Merck KGaA